Panel Discussion: Harnessing the Benefits of Collaborative Partnerships to Pave the Way for Innovation during Significant Regulatory Shifts
Time: 9:50 am
day: Day One
Details:
- An Overview of the Final LDT Rule
- Exploring the impact of the new regulatory pathway conditions on the safety and efficacy of LDT’s
- Selecting the right partnership to expedite clinical trials during regulatory shifts
- Exploring how choosing the right partners can mitigate risks associated with regulatory shifts
- Clinical trial assay development versus commercial development dynamics
- Future considerations for partnerships with an ever-changing regulatory landscape
